Rituximab in CD20 positive multiple myeloma
- PMID: 17972949
- DOI: 10.1038/sj.leu.2405010
Rituximab in CD20 positive multiple myeloma
Comment in
-
Reply to 'Rituximab activity in CD20-positive multiple myeloma'.Leukemia. 2008 May;22(5):1083; author reply 1083-4. doi: 10.1038/sj.leu.2405011. Epub 2007 Nov 1. Leukemia. 2008. PMID: 17972948 No abstract available.
Comment on
-
Rituximab in CD20 positive multiple myeloma.Leukemia. 2007 Apr;21(4):835-6. doi: 10.1038/sj.leu.2404558. Epub 2007 Feb 1. Leukemia. 2007. PMID: 17268523 Clinical Trial. No abstract available.
-
Treatment of severe autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab.Leukemia. 2007 Aug;21(8):1841-2; author reply 1842-3. doi: 10.1038/sj.leu.2404713. Epub 2007 Apr 26. Leukemia. 2007. PMID: 17460703 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
